MedTech Archive - Pharmabusinessblog

Cutting edge tax implications for medical devices suppliers in Europe

Medical devices suppliers conducting agreements for allowing hospitals to use free of charge their equipment might face both VAT and corporate tax adverse implications.

Event: “Tax Engineering” für MedTech – 19. März 2020, PwC Luzern

Innovation gilt als Kernwert des Wirtschaftsstandorts Schweiz – und der MedTech-Branche. Das Volks-Ja zur Steuerreform hat der innovativen Tätigkeit von Unternehmen wie Ihrem eine neue Bedeutung verliehen. Auch andere nationale und internationale Neuerungen der indirekten Steuern und Zölle sowie neue regulatorische Rahmenbedingungen wirken sich 2020 auf die aktuelle und zukünftige Situation Ihres Unternehmens aus.

Wie daraus ein echter Mehrwert generiert werden kann, möchten wir gerne an unserem speziell der MedTech Branche gewidmeten Event mit Ihnen diskutieren.

Swiss Medtech companies – action required for the sale of products in the EU as per May 2020 – Is your business ready for the upcoming changes?

1. The background in a nutshell

Until 25th May 2020 all Medtech products that are admitted in Switzerland for the sale can be distributed also in the EU.
However, currently a new treaty is negotiated by Switzerland and the EU Joint Committee in that regard.
In case the treaty is not going to be concluded between Switzerland and the EU, all Medtech companies based in Switzerland are considered as not being anymore part of the EU. Indeed this treaty hangs by a hair.

Following the latest developments of the Swiss-EU negotiations concerning the Institutional Agreement and the Mutual Recognition Agreement (MRA), Swiss Medtech companies should be preparing for the case in which MRA would no longer apply to the medical devices after 26th May 2020.